Product Description
BMS-754807 is a potent and reversible inhibitor of the insulin-like growth factor 1 receptor/insulin receptor (IGF-1R/IR) family kinases (Ki, <2 nmol/L). BMS-754807 effectively inhibits the growth of a broad range of human tumor types in vitro, including mesenchymal, epithelial, and hematopoietic tumor cell lines (IC₅₀, 5–365 nmol/L).
BMS-754807 is a potent and reversible inhibitor of the insulin-like growth factor 1 receptor/insulin receptor (IGF-1R/IR) family kinases (Ki, <2 nmol/L). BMS-754807 effectively inhibits the growth of a broad range of human tumor types in vitro, including mesenchymal, epithelial, and hematopoietic tumor cell lines (IC₅₀, 5–365 nmol/L).
Biovision | 2631 | BMS-754807 DataSheet
Alternate Name/Synonyms: (S)-1-(4-((5-cyclopropyl-1H-pyrazol-3-yl)amino)pyrrolo[2,1-f][1,2,4]triazin-2-yl)-N-(6-fluoropyridin-3-yl)-2-methylpyrrolidine-2-carboxamide; BMS754807
Appearance: White to off-white solid
Formulation: N/A
CAS Number: 1001350-96-4
Structure Available?: Y
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₃H₂₄FN₉O
Molecular Weight: 461.49
Cell-Permeable?: Yes
Purity: >98% by HPLC
Solubilities: DMSO
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A potent IGF-1R/IR inhibitor
MDL Number: N/A
PubChem CID: 24785538
SMILES: CC1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F
InChi: InChI=1S/C23H24FN9O/c1-23(21(34)26-15-7-8-18(24)25-13-15)9-3-10-32(23)22-28-20(17-4-2-11-33(17)31-22)27-19-12-16(29-30-19)14-5-6-14/h2,4,7-8,11-14H,3,5-6,9-10H2,1H3,(H,26,34)(H2,27,28,29,30,31)/t23-/m0/s1
InChi Key: LQVXSNNAFNGRAH-QHCPKHFHSA-N